Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
Published on: August 23, 2024
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors
Hülya Dogan1, Martin Liptay1, Joana S Barbosa1
1Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, 3012, Switzerland.
Abstract:
MDC1 is a key protein in DNA damage signaling. When DNA double-strand breaks (DSBs) occur, MDC1 localizes to the sites of DNA damage to promote the recruitment of other factors, including the 53BP1-mediated DSB repair pathway. By studying mechanisms of poly (ADP-ribose) polymerase inhibitor (PARPi) resistance in BRCA2; p53-deficient mouse mammary tumors, we identified a thus far unknown role of MDC1 in replication fork biology. Our results show that MDC1 localizes at active replication forks during normal DNA replication and regulates replication fork progression. It suppresses spontaneous fork reversal and regulates fork nucleolytic processing thereby promoting sensitivity to PARPi and cisplatin. In this way, MDC1 loss improves DNA damage tolerance and causes chemoresistance in BRCA1/2-deficient cells. We demonstrate that limiting MRE11 activity abolishes the reduced fork speed while MRE11 inhibition/depletion overcomes PARPi resistance in these cells. Overall, our data provides new insights into the role of MDC1 in replication fork progression that mediates PARPi- and cisplatin-induced DNA damage, in addition to its role in DSB repair.
Insights
Mediator of DNA damage checkpoint 1 (MDC1) protein is crucial for DNA repair and replication fork stability. Loss of MDC1 promotes chemoresistance in BRCA1/2-deficient cells by altering DNA damage tolerance.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Mediator of DNA damage checkpoint 1 (MDC1) is a key protein in DNA damage signaling, particularly in response to DNA double-strand breaks (DSBs).
- MDC1 facilitates the recruitment of repair factors, such as those involved in the 53BP1-mediated DSB repair pathway.
- Understanding mechanisms of poly (ADP-ribose) polymerase inhibitor (PARPi) resistance is critical for cancer therapy.
Purpose of the Study:
- To investigate the role of MDC1 in replication fork biology and its contribution to PARPi resistance in BRCA2-deficient, p53-deficient mouse mammary tumors.
- To elucidate how MDC1 influences DNA damage tolerance and sensitivity to chemotherapeutic agents like PARPi and cisplatin.
Main Methods:
- Analysis of BRCA2; p53-deficient mouse mammary tumors to study PARPi resistance mechanisms.
- Investigation of MDC1 localization at active replication forks during normal DNA replication.
- Assessment of MDC1's role in regulating replication fork progression, fork reversal, and nucleolytic processing.
- Evaluation of MRE11 activity's impact on fork speed and PARPi resistance.
Main Results:
- MDC1 localizes to active replication forks and regulates their progression during normal DNA replication.
- MDC1 suppresses spontaneous replication fork reversal and controls fork nucleolytic processing, promoting sensitivity to PARPi and cisplatin.
- Loss of MDC1 enhances DNA damage tolerance and confers chemoresistance in BRCA1/2-deficient cells.
- Limiting MRE11 activity reduces fork speed and overcomes PARPi resistance in MDC1-deficient cells.
Conclusions:
- MDC1 plays a significant role in replication fork progression, influencing sensitivity to DNA-damaging agents.
- MDC1's function at replication forks is distinct from its established role in DSB repair.
- Targeting MRE11 activity presents a potential strategy to overcome PARPi resistance in cancers with altered MDC1 function.
Related Concept Videos
Restarting Stalled Replication Forks
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The DNA Replication Fork
Negative Regulator Molecules

